|
|
From NeuroLex
| Abbrev
|
CHARTER +
|
| Address
|
CNS HIV Anti-Retroviral Therapy Effects Research +,
University of California +,
San Diego +,
220 Dickinson Street +,
Suite B +,
MC8231 +,
CA 92103-8231 Telephone: (619) 543-5000 Fax: (619) 543-1235 E-mail: charter (at) ucsd.edu +
|
| Availability
|
Public: To qualified investigators +
|
| Comment
|
Sample type: Bodily fluid, Cerebral Spinal Fluid, Plasma, Serum, DNA, RNA
|
| CurationStatus
|
curated +
|
| DefiningCitation
|
https://www.charterresource.ucsd.edu/ +
|
| Definition
|
Clinical trial designed to determine how c … Clinical trial designed to determine how central and peripheral nervous system complications of HIV are affected by different histories and regimens of antiretroviral therapy (ART). Participants receive comprehensive neuromedical, neurocognitive, and laboratory examinations, with a subset undergoing host/viral genetic characterization and neuroimaging. In order to have a broad representation of participant characteristics, CHARTER is conducted at six performance sites nationally. CHARTER data and samples are available to qualified investigators. CHARTER is able to provide fluid specimens, pilot data, and analysis and interpretation expertise for qualified investigators.
The project is designed to assess a large number of HIV infected participants with a baseline visit only, and to follow approximately 600 of those individuals on a semi-annual basis. Approximately 180 individuals will continue to be followed through August 2015. All participants are HIV seropositive and complete a Core battery of neuromedical, laboratory, neuropsychological, and psychiatric assessments. A subset of those in the longitudinal cohort complete additional measures (e.g., CSF studies, structural MRI, proton spectroscopy, viral genetic analyses).
Data Resources
* Neuromedical Data: Medical History; Detailed ARV History; CDC Classification; ARV Adherence Estimates; Characteristics of Neurologic Disorders (e.g. Peripheral Neuropathy); Risk Group (sexual contact, IDU, transfusion, vertical); Anthropomorphic Measures
* Laboratory Data: Hematology Chemistry, Renal, and Hepatic Panels; Lipid Panels (select participants); Hepatitis Serologic Panels; Lactate (select participants); Lymphocyte Subsets HIV RNA; Plasma and CSF ARV Concentrations; Plasma Psychotropic Drug Concentrations; Biomarkers (cytokines, etc.); Host Genotyping
* Neurobehavioral Data: NP Characterization (raw, T scores, impairment classification); Substance Use History /Diagnoses; Psychiatric History/Diagnoses; Self-report Functioning Data; Mood Scales
* Neuroimaging Data (Select Participants): Structural MRI (white/gray matter abnormalities/volume loss); MR Spectroscopy (N-acetylaspartate, Choline, Myo-inositol levels); Diffusion Tensor Imaging (diffusion anisotropy)
* Virology Data (Select participants): Plasma genotypic ARV resistance, CSF genotypic ARV resistance
* Specimen Resources: CSF aliquots, Plasma aliquots, Serum aliquots, PAXGene DNA tubes, PAXGene RNA tubes
* Cohort Resources: Currently following 180 Participants; ~1600 Participants with Baseline visit; 674 Participants with at least 1 Follow-up visit; 141 Aging cohort (>55 years of age); 50 Acute and Early Infection Cohort (1st HIV+ test date within 1 year of first study visit) t date within 1 year of first study visit)
|
| ExampleImage
|
CHARTER.PNG +
|
| Grant
|
Category:HHS-N-271-2010-00036C +,
Category:HHSN271201000030C +
|
| Has default formThis property is a special property in this wiki.
|
Resource +
|
| Has role
|
Topical portal +,
Data or information resource +,
Biomaterial supply resource +,
Clinical trial +
|
| Id
|
nif-0000-10520 +
|
| Is part of
|
University of California at San Diego; California; USA +
|
| Keywords
|
Bodily fluid +,
Cerebral Spinal Fluid +,
Plasma +,
Serum +,
DNA +,
RNA +,
Human immunodeficiency virus +,
Human immunodeficiency virus seropositive +,
Antiretroviral +,
Antiviral therapy +,
Clinical +,
Human +,
Neurobehavioral +,
Neurocognitive +,
Neurological +,
Neuromedical +,
Neuropsychological +,
Proton spectroscopy +,
Psychiatric +,
Structural MRI +,
Viral +,
Viral genetic analyses +,
Virology +,
Neuroimaging +,
Central nervous system +,
Clinical data +,
Longitudinal +,
Neuropsychological assessment +,
Psychiatric assessment +,
MR Spectroscopy +
|
| Label
|
Resource:CHARTER: CNS HIV Antiretroviral Therapy Effects Research +
|
| Modification dateThis property is a special property in this wiki.
|
21 March 2013 17:29:01 +
|
| ModifiedDate
|
21 March 2013 +
|
| Page has default formThis property is a special property in this wiki.
|
Resource +
|
| RelatedTo
|
Resource:One Mind Biospecimen Bank Listing +,
US Biobank +
|
| Related application
|
Research +
|
| Related disease
|
Human immunodeficiency virus +,
Human immunodeficiency virus seropositive +
|
| Species
|
Human +
|
| SuperCategory
|
Resource +
|
| Supporting Agency
|
National Institutes of Health +,
National Institute of Mental Health +,
National Institute of Neurological Disorders and Stroke +
|
| Synonym
|
CNS HIV Anti-Retroviral Therapy Effects Research +
|
| Categories |
Resource
|
| | No properties link to this page. |
|---|
|
|
